|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-12-5
|
|
pubmed:abstractText |
Interferon beta (INFbeta) may induce the expression of several proteins, including neopterin, considered a biological marker of INFbeta activity.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0001-6314
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
109
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
61-5
|
|
pubmed:dateRevised |
2010-3-23
|
|
pubmed:meshHeading |
pubmed-meshheading:14653852-Adjuvants, Immunologic,
pubmed-meshheading:14653852-Adult,
pubmed-meshheading:14653852-Biological Markers,
pubmed-meshheading:14653852-Female,
pubmed-meshheading:14653852-Humans,
pubmed-meshheading:14653852-Injections, Intramuscular,
pubmed-meshheading:14653852-Interferon-beta,
pubmed-meshheading:14653852-Male,
pubmed-meshheading:14653852-Multiple Sclerosis,
pubmed-meshheading:14653852-Neopterin,
pubmed-meshheading:14653852-Sensitivity and Specificity,
pubmed-meshheading:14653852-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Is serum neopterin level a marker of responsiveness to interferon beta-1a therapy in multiple sclerosis?
|
|
pubmed:affiliation |
Department of Neurology, University of Modena, Modena, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
